High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).

Autor: Ouk, V, Heng, L Say, Virak, M, Deng, S, Lahra, M M, Frankson, R, Kreisel, K, McDonald, R, Escher, M, Unemo, M, Wi, T, Maatouk, I, Group, EGASP Cambodia Working

Publikováno v: JAC-Antimicrobial Resistance; Apr2024, Vol. 6 Issue 2, p1-7, 7p

Prevalence of sexually transmitted infections and associated risk factors among female sex workers in Guinea-Bissau.

Autor: Lindman J; The Department of Clinical Sciences Lund, Lund University, Lund, Sweden jacob.lopatko_lindman@med.lu.se., Djalo MA; Environmental Action in the Third World (ENDA), Bissau, Guinea-Bissau., Biai A; The National Public Health Laboratory, Bissau, Guinea-Bissau., Månsson F; The Department of Translational Medicine, Lund University, Malmö, Sweden., Golparian D; WHO Collaborating Centre for Gonorrhea and Other STIs, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden., Esbjörnsson J; The Department of Translational Medicine, Lund University, Malmö, Sweden., Jansson M; The Department of Laboratory Medicine, Lund University, Lund, Sweden., Medstrand P; The Department of Laboratory Medicine, Lund University, Lund, Sweden., Unemo M; WHO Collaborating Centre for Gonorrhea and Other STIs, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden.; Institute for Global Health, University College London, London, UK., Norrgren H; The Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Publikováno v: Sexually transmitted infections [Sex Transm Infect] 2024 Oct 17; Vol. 100 (7), pp. 411-417. Date of Electronic Publication: 2024 Oct 17.

In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.

Autor: David A; Institute for Global Health, Faculty of Population Health, University College London, London, UK., Golparian D; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Jacobsson S; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Stratton C; Department of Biochemistry and Molecular Biology, University of South Alabama, AL, USA., Lan PT; Hanoi Medical University, National Hospital of Dermatology and Venereology, Hanoi, Vietnam., Shimuta K; Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan., Sonnenberg P; Institute for Global Health, Faculty of Population Health, University College London, London, UK., Field N; Institute for Global Health, Faculty of Population Health, University College London, London, UK., Ohnishi M; Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan., Davies C; Department of Biochemistry and Molecular Biology, University of South Alabama, AL, USA., Unemo M; Institute for Global Health, Faculty of Population Health, University College London, London, UK.; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2221-2226.

Erratum for Balthazar et al., "A laboratory-based predictive pathway for the development of Neisseria gonorrhoea e high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase".

Autor: Balthazar JT, Golparian D, Unemo M, Read TD, Grosse M, Stadler M, Pfarr K, Schiefer A, Hoerauf A, Edwards JL, Vassylyev DG, Shafer WM

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2024 Aug 06; Vol. 12 (8), pp. e0140624. Date of Electronic Publication: 2024 Jul 01.

Vaccine value profile for Neisseria gonorrhoeae.

Autor: Lyu Y; University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: ylyu6@student.unimelb.edu.au., Choong A; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia. Electronic address: annabellec@student.unimelb.edu.au., Chow EPF; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia; Melbourne Sexual Health Centre, Alfred Health, 580 Swanston Street, Melbourne, Victoria 3053, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Melbourne, Victoria 3053, Australia. Electronic address: echow@mshc.org.au., Seib KL; Institute for Glycomics, Griffith University, Gold Coast, Queensland 4222, Australia. Electronic address: k.seib@griffith.edu.au., Marshall HS; The University of Adelaide, Adelaide, South Australia 5005, Australia; Women's and Children's Health Network, North Adelaide, South Australia, Australia. Electronic address: helen.marshall@adelaide.edu.au., Unemo M; WHO CC for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden; Institute for Global Health, University College London (UCL), London, UK. Electronic address: magnus.unemo@regionorebrolan.se., de Voux A; Division of Epidemiology and Biostatistics, Faculty of Health Sciences, University of Cape Town, Rondebosch, Cape Town 7700, South Africa. Electronic address: alex.devoux@uct.ac.za., Wang B; The University of Adelaide, Adelaide, South Australia 5005, Australia; Women's and Children's Health Network, North Adelaide, South Australia, Australia. Electronic address: bing.wang@adelaide.edu.au., Miranda AE; Department of Social Medicine, Universidade Federal do Espirito Santo, Av. Fernando Ferrari, 514 - Goiabeiras, Vitória - ES 29075-910, Brazil. Electronic address: angelica.miranda@ufes.br., Gottlieb SL; Department of Sexual and Reproductive Health and Research, World Health Organization, Av. Appia 20, 1211 Genève, Switzerland. Electronic address: gottliebs@who.int., Mello MB; Global HIV, Hepatitis and STI Programmes, World Health Organization, Av. Appia 20, 1211 Genève, Switzerland. Electronic address: demellmae@who.int., Wi T; Global HIV, Hepatitis and STI Programmes, World Health Organization, Av. Appia 20, 1211 Genève, Switzerland. Electronic address: wit@who.int., Baggaley R; Global HIV, Hepatitis and STI Programmes, World Health Organization, Av. Appia 20, 1211 Genève, Switzerland. Electronic address: baggaleyr@who.int., Marshall C; Department of Immunization, Vaccines and Biologicals, World Health Organization, Av. Appia 20, 1211 Genève, Switzerland. Electronic address: cmarshall@who.int., Abu-Raddad LJ; Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Box 24144, Doha, Qatar. Electronic address: lja2002@qatar-med.cornell.edu., Abara WE; Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA. Electronic address: wabara@cdc.gov., Chen XS; National Center for STD Control of China CDC, 12 Jiangwangmiao Street, Nanjing 210042, China. Electronic address: chenxs@ncstdlc.org., Ong JJ; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia. Electronic address: jason.ong@monash.edu.

Publikováno v: Vaccine [Vaccine] 2024 Jul 25; Vol. 42 (19S1), pp. S42-S69. Date of Electronic Publication: 2023 Dec 13.